USD 1.41
(-0.28%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.5 Million USD | 5349.94% |
2022 | 46 Thousand USD | -77.11% |
2021 | 201 Thousand USD | -97.26% |
2020 | 7.32 Million USD | 13992.31% |
2019 | 52 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 9453.00 USD | -99.6% |
2014 | 2.38 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - USD | -100.0% |
2024 Q1 | 2.86 Million USD | 0.0% |
2023 FY | 2.5 Million USD | 5349.94% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q1 | 11 Thousand USD | -76.09% |
2023 Q2 | - USD | -100.0% |
2022 Q2 | 110 Thousand USD | -33.33% |
2022 Q4 | 46 Thousand USD | -43.21% |
2022 FY | 46 Thousand USD | -77.11% |
2022 Q1 | 165 Thousand USD | -17.91% |
2022 Q3 | 81 Thousand USD | -26.36% |
2021 Q1 | 6.8 Million USD | -7.15% |
2021 FY | 201 Thousand USD | -97.26% |
2021 Q4 | 201 Thousand USD | -93.98% |
2021 Q3 | 3.33 Million USD | -26.64% |
2021 Q2 | 4.55 Million USD | -33.13% |
2020 FY | 7.32 Million USD | 13992.31% |
2020 Q2 | 46 Thousand USD | -6.12% |
2020 Q1 | 49 Thousand USD | -5.77% |
2020 Q3 | 43 Thousand USD | -6.52% |
2020 Q4 | 7.32 Million USD | 16941.86% |
2019 Q4 | 52 Thousand USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 FY | 52 Thousand USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | 9453.00 USD | -99.6% |
2015 Q3 | - USD | 0.0% |
2014 FY | 2.38 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Theratechnologies Inc. | 51.26 Million USD | 95.109% |
Safety Shot Inc | 304.9 Thousand USD | -722.209% |
Biofrontera Inc. | 804 Thousand USD | -211.813% |
DURECT Corporation | 2.7 Million USD | 7.218% |
Cosmos Health Inc. | 3.03 Million USD | 17.407% |
Cronos Group Inc. | 1.55 Million USD | -60.807% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 99.5% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 99.497% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | 92.668% |
RedHill Biopharma Ltd. | 455 Thousand USD | -450.983% |
Organogenesis Holdings Inc. | 60.74 Million USD | 95.873% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | 75.561% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -365.086% |
Alpha Teknova, Inc. | 13.25 Million USD | 81.081% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | 81.187% |
SCYNEXIS, Inc. | 12.15 Million USD | 79.382% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 99.19% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -2781.579% |
Dynavax Technologies Corporation | 252.41 Million USD | 99.007% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 97.247% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -646.143% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 97.92% |
Shineco, Inc. | 10.01 Million USD | 74.974% |
Indivior PLC | 235.66 Million USD | 98.936% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Radius Health, Inc. | 339.66 Million USD | 99.262% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -365.086% |
Incannex Healthcare Limited | 210 Thousand USD | -1093.797% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -2040.353% |
Alimera Sciences, Inc. | 64.48 Million USD | 96.113% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -1755.794% |
Alvotech | 1.02 Billion USD | 99.756% |
Journey Medical Corporation | 14.62 Million USD | 82.855% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | 63.441% |
Embecta Corp. | 1.62 Billion USD | 99.846% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -11050.036% |
Procaps Group, S.A. | 28.41 Million USD | 91.176% |
PainReform Ltd. | 30 Thousand USD | -8256.58% |
Harrow Health, Inc. | 183.17 Million USD | 98.631% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 92.448% |
OptiNose, Inc. | 611 Thousand USD | -310.307% |
Kamada Ltd. | 7.43 Million USD | 66.295% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 80.39% |
Phibro Animal Health Corporation | 458.28 Million USD | 99.453% |
Procaps Group S.A. | 28.41 Million USD | 91.176% |
TherapeuticsMD, Inc. | 6.53 Million USD | 61.62% |
Talphera, Inc. | - USD | -Infinity% |
Viatris Inc. | 16.18 Billion USD | 99.985% |
Rockwell Medical, Inc. | 8.29 Million USD | 69.77% |
Aytu BioPharma, Inc. | 10.87 Million USD | 76.952% |
Tilray Brands, Inc. | 287.93 Million USD | 99.129% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 99.488% |
PetIQ, Inc. | 437.82 Million USD | 99.427% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 99.029% |
Assertio Holdings, Inc. | 38.51 Million USD | 93.491% |
Lantheus Holdings, Inc. | 616.12 Million USD | 99.593% |
Avadel Pharmaceuticals plc | 32.75 Million USD | 92.347% |
Hempacco Co., Inc. | 5.93 Million USD | 57.731% |
Pacira BioSciences, Inc. | 513.79 Million USD | 99.512% |
Alvotech | 1.02 Billion USD | 99.756% |
Evoke Pharma, Inc. | 5 Million USD | 49.861% |
Flora Growth Corp. | 942 Thousand USD | -166.133% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -11050.036% |
Evolus, Inc. | 120.35 Million USD | 97.917% |
HUTCHMED (China) Limited | 48.18 Million USD | 94.798% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 99.575% |
Akanda Corp. | 2.49 Million USD | -0.393% |